Evaluation of Salivary Gland Dysfunction
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will evaluate patients with complaints of dry mouth to determine the cause and severity of their salivary gland dysfunction and their possible eligibility for other NIDCR protocols. Salivary gland secretions have antibacterial, lubricatory, remineralizing, digestive, buffering and cleansing properties. Impaired function of these glands can cause an increase in tooth decay; a variety of oral hard and soft tissue changes, with painful, burning, or ulcerated oral mucosal; problems chewing, swallowing, and speaking; and diminished taste and smell.
Patients with dry mouth complaints suggestive of salivary gland dysfunction may be eligible for this study. In addition, patients with recent onset of arthritis may enroll. Patients with arthritis are at risk for developing a disorder called Sjogren's syndrome, in which the glands that produce saliva may be damaged.
Participants will have a complete medical and dental history. Saliva samples will be collected from the major salivary glands, which are located in the cheeks and under the jaw. Several blood samples will also be drawn for tests. Some patients will have a biopsy of the minor salivary glands, usually from the lower lip, to confirm or rule out the diagnosis of Sjogren's syndrome and determine the extent of changes in the salivary glands. The ability to taste and smell may also be evaluated, and patients may have an ultrasound examination of their swallowing function.
| Condition |
|---|
|
Sjogren's Syndrome Xerostomia |
| Study Type: | Observational |
| Official Title: | Evaluation of Salivary Gland Dysfunction |
| Estimated Enrollment: | 99999999 |
| Study Start Date: | March 1984 |
This study will evaluate participants with complaints of dry mouth to determine the cause and severity of their salivary gland dysfunction and their possible eligibility for other NIDCR protocols. Salivary secretions have antibacterial, lubricating, remineralizing, digestive, buffering and cleansing properties. Impaired function of these glands can cause an increase in tooth decay; a variety of oral hard and soft tissue changes, with painful, burning or ulcerated or oral mucosa; problems chewing, swallowing and speaking; and diminished taste and smell.
Participants with dry mouth complaints suggestive of salivary gland dysfunction may be eligible for this study.
Participants will have a complete medical and dental history. Saliva samples will be collected from the major salivary glands, which are located in the cheeks and under the tongue. Several blood samples will also be drawn for tests. Some participants will have a biopsy of the minor salivary glands, usually from inside the lower lip, to confirm or rule out the diagnosis of Sjogren's syndrome and to determine the extent of changes in the salivary glands. An eye examination including a standard eye examination and a dry eye assessment is done. The ability to taste and smell may also be evaluated, and participants may have an ultrasound examination of their swallowing function.
Eligibility| Ages Eligible for Study: | 12 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA:
- Subjects must have dry mouth symptoms (xerostomia) or a reasonable clinical suspicion of having Sjogren's syndrome or other salivary gland disease
- Ability to provide informed consent.
EXCLUSION CRITERIA:
a. Age less than 12 years.
Contacts and Locations| Contact: Lolita Bebris, R.N. | (301) 594-1644 | bebrisl@mail.nih.gov |
| Contact: Ilias G Alevizos, D.M.D. | (301) 496-6207 | alevizosi@mail.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov | |
| Principal Investigator: | Ilias G Alevizos, D.M.D. | National Institute of Dental and Craniofacial Research (NIDCR) |
More Information
Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00001196 History of Changes |
| Other Study ID Numbers: | 840056, 84-D-0056 |
| Study First Received: | November 3, 1999 |
| Last Updated: | June 18, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Parotid Gland Submandibular/Sublingual Glands Xerostomia |
Radiation Therapy Sjogren's Syndrome Dry Mouth |
Additional relevant MeSH terms:
|
Sjogren's Syndrome Xerostomia Salivary Gland Diseases Mouth Diseases Stomatognathic Diseases Arthritis, Rheumatoid Arthritis Joint Diseases |
Musculoskeletal Diseases Rheumatic Diseases Dry Eye Syndromes Lacrimal Apparatus Diseases Eye Diseases Connective Tissue Diseases Autoimmune Diseases Immune System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013